Altimmune, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 7 of 7 Posts
Altimmune Selloff On Clinical Hold A Buying Opportunity, Says JMP Securities
Article By: The Fly Thursday, December 24, 2020 7:05 AM EDT
After speaking with management, JMP Securities analyst Jonathan Wolleben expects Altimmune to resolve the AdCOVID IND clinical hold in early January with Phase 1 data still expected in Q1.
In this article: ALT
Read
E US Stock Market Weekly Review Aug. 23-28
Article By: Stavros Georgiadis Saturday, August 29, 2020 11:49 PM EDT
The valuations of stocks at these new record highs are of major concern.
In this article: CPST, ALT, VXRT, VVPR
Read
64 Biggest Movers From Yesterday
Article By: Benzinga Thursday, August 27, 2020 5:04 AM EDT
Here are the best gainers and losers moving in pre-market.
In this article: DKS, EXPR, LRN, RIG, AMTX, FARM, CRM, DY, JWN, NIO, VHI, CHCI, GEVO, KIRK, BKYI, FLDM, INOD, CYRX, IMBI, VNET, BGFV, PEIX, ADBE, HIBB, KELYB, URBN, PPSI, NFLX, CAAS, CNSP, GOGO, WORX, WDAY, VJET, HPE, NAKD, ALT, PLAN, XSPA, TRUP, PSTG, OCUL, ANY, LPCN, CWBR, BIGC, EVSI, FLNT, MICT, GTX, IMUX, SWBI, SONN, BRQS, ORTX, UONE, BLI, RUHN, AYRO, EDNT, KROS, LI, OCGN, DNK
Read
Altimmune Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Article By: NASDAQ GlobeNewswire Monday, July 13, 2020 8:09 PM EDT
Altimmune, Inc., today announced that it intends to offer and sell shares of its common stock in an underwritten public offering and, to certain investors in lieu thereof, pre-funded warrants to purchase shares of its common stock.
In this article: ALT
Read
These Are Some Of The Coronavirus Vaccine Candidates
Article By: ValueWalk Monday, May 25, 2020 6:28 PM EDT
As far as which coronavirus vaccine candidates will be tested first, researchers will look at production capacity and the amount of immune response generated in early trials and animal studies.
In this article: GSK, PFE, SNY, MRNA, ALT, JNJ, SVA, NVAX, INO, AZN
Read
Altimmune Announces $25 Million Registered Direct Offering
Article By: NASDAQ GlobeNewswire Monday, October 8, 2018 11:00 PM EDT
Altimmune, Inc. today announced it has entered into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering.
In this article: ALT
Read
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
Article By: NASDAQ GlobeNewswire Thursday, August 17, 2017 2:59 PM EDT
Altimmune, Inc., today announced it has entered into a definitive securities purchase agreement with new and existing investors to sell an aggregate of 15,656 shares of Series B convertible preferred stock and warrants.
In this article: ALT
Read
1 to 7 of 7 Posts